US STOCK
TVTX Stock Analysis
US stocks · market data · technical indicators
Travere Therapeutics, Inc.
TVTXUS stocksQuote delayed 15 min
9/11 下午08:00 updated
$67.51
+1.29+1.95%
Open
$65.60
High
$68.59
Low
$64.45
Volume
155.91萬
TVTX price history
+8.61%Open
62.16
Latest
67.51
High
67.52
Low
61.43
Average
65.37
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score65
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$67.51
Target Price$77.637
Change %+1.95%
Institutional
Moderate
Foreign Ownership
Moderate
Market Heat
Positive
Market Insight
The score sits in neutral territory (65/100). Waiting for a clearer signal may be warranted. The target price implies roughly 15.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| STATE STREET CORP | 2026-06-30 | $241.8M | 0.01% |
| VANGUARD GROUP INC | 2025-12-31 | $241.1M | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $104.1M | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $88.9M | 0.06% |
| BlackRock Inc. | 2024-06-30 | $62.8M | 0.00% |
| CITADEL ADVISORS LLC | 2026-06-30 | $2.2M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$74.21
Target range
$62.00 – $90.00
Implied upside
9.93%
Strong buy
2
Buy
12
Hold
1
Sell
0
Strong sell
0
Advertisement